Global Cystic Fibrosis Market Report 2024: Growth Amid Rising Prevalence and Innovative Therapeutic Developments - Forecasts to 2029
21 juin 2024 06h58 HE
|
Research and Markets
Dublin, June 21, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Market - Forecasts from 2024 to 2029" report has been added to ResearchAndMarkets.com's offering. Emerging Therapeutics and...
Global Cystic Fibrosis Market Analysis & Forecasts 2024-2034: Focus on Mucolytics, Bronchodilators, Cystic Fibrosis Transmembrane Conductance Regulator Modulators, & Pancreatic Enzyme Supplements
13 juin 2024 10h08 HE
|
Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Global Cystic Fibrosis Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global cystic...
Cystic Fibrosis Devices Global Strategic Business Report 2024: Market to Reach $1.6 Billion by 2030 AbbVie, Allergan Plc, AstraZeneca at the Forefront
13 juin 2024 05h57 HE
|
Research and Markets
Dublin, June 13, 2024 (GLOBE NEWSWIRE) -- The "Cystic Fibrosis Devices - Global Strategic Business Report" report has been added to ResearchAndMarkets.com's offering.The global market for Cystic...
Novotech Publishes Analyst Report on Cystic Fibrosis Clinical Trial Landscape to Inform Biotech Research Planning
10 avr. 2024 22h33 HE
|
Novotech
The report presents a data-backed review of the Cystic Fibrosis (CF) funding landscape, trial density, and patient recruitment data.
Global Cystic Fibrosis Market Analysis & 10 Year Forecast 2024-2034: By Drug Class, CFTR Modulators was the Highest Revenue-Grossing Segment in the Global Cystic Fibrosis Market in 2023
09 avr. 2024 04h13 HE
|
Research and Markets
Dublin, April 09, 2024 (GLOBE NEWSWIRE) -- The "Global Cystic Fibrosis Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering.The global cystic...
First Wave BioPharma to Participate In ‘Fireside Chat’ at the 36th Annual Roth Conference
05 mars 2024 07h00 HE
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., March 05, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
Soft Mist Inhalers Market Size Projected to Grow at a 6.8% CAGR, Globally, by 2031 - Exclusive Report by Transparency Market Research, Inc.
29 févr. 2024 01h45 HE
|
Transparency Market Research
Wilmington, Delaware, United States, Feb. 29, 2024 (GLOBE NEWSWIRE) -- Transparency Market Research Inc. - The global soft mist inhalers market is projected to grow at a CAGR of 6.8% from 2022 to...
First Wave BioPharma CEO to Present at the BIO CEO & Investor Conference 2024
13 févr. 2024 07h00 HE
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Feb. 13, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
First Wave BioPharma to Present at the DealFlow MicroCap Conference
23 janv. 2024 07h00 HE
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Jan. 23, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...
First Wave BioPharma CEO to Present at the Sequire Investor Summit 2024 in Puerto Rico
17 janv. 2024 07h00 HE
|
First Wave BioPharma, Inc.
BOCA RATON, Fla., Jan. 17, 2024 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ: FWBI), (“First Wave BioPharma” or the “Company”), a clinical-stage biopharmaceutical company specializing in...